mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
NI

Novartis India Limited

NSE:EVONILEBSE:EVONILE
HealthcarePharmaceuticals & Biotechnology
₹1,568.1
-15.93%11 Nov close
Mkt cap
₹3,873 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&OFund holdersDocumentsEventsAnnouncementsNotes
QuarterlyAnnual

Year ends (Mar) · % of equity

Holder (%)Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
70.68%70.68%70.68%70.68%70.68%
0%0.17%0.19%0.19%0.17%
0%0.79%0.53%0.53%0.53%
Government0%0%0%0%0%
29.32%28.36%28.6%28.6%28.62%
No. of shareholders————38,116

Promoter holding up 0 percentage points since Mar 2022. One column per financial year, taken from the register filed at that year end.

2 deals · 7 Sept 2026 – 7 Sept 2026
DateClientTypeVenueSideQuantityPriceValue
7 Sept 2026KYRUSH INVESTMENTSBulkBSESell1,30,000₹1,670.50₹21.72 Cr
7 Sept 2026KARAN BHAGATBulkBSEBuy1,30,000₹1,670.52₹21.72 Cr
1–2 of 2
1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

  • Mr. CHRISTOPHER DAVID SNOOKNon-Executive - Non Independent Director-Chairperson
  • Ms. GIRA JAGDEESH SARDESAINon-Executive - Independent Director
  • Mr. SANKER PARAMESWARANNon-Executive - Independent Director
  • Ms. GOWREE GOKHALENon-Executive - Independent Director
  • Ms. SHILPA SHASHANK JOSHIExecutive Director
  • Mr. FALIN ISHWARLAL MAJMUDARExecutive Director
  • Ms. Chandni MaruCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.